Overview of Dr. Chan
Dr. Onyee Chan is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from University of Arizona College of Medicine - Phoenix and has been in practice 4 years. She is one of 173 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. She has more than 60 publications and over 500 citings.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2017 - 2020
- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2014 - 2017
- University of Arizona College of Medicine - PhoenixClass of 2014, MD
Certifications & Licensure
- FL State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsData-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.Rami S Komrokji, Luca Lanino, Somedeb Ball, Jan P Bewersdorf, Monia Marchetti
The Lancet. Haematology. 2024-11-01 - 1 citationsInfluence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion.Maria Julia Montoro, Laura Palomo, Claudia Haferlach, Pamela Acha, Onyee Chan
Blood. 2024-10-17 - 2 citationsOutcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment.Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli, David A Sallman, Justine Decroocq
American Journal of Hematology. 2024-10-01
Abstracts/Posters
- OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid LeukemiaOnyee Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Hypomethylating Agent and Venetoclax Combination Yields Comparable Outcomes to CPX-351 in Newly Diagnosed Acute Myeloid LeukemiaOnyee Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Hypomethylating Agent and Venetoclax Combination Therapy Yields Superior Outcomes When Compared to Hypomethylating Agent Monotherapy in Patients _70 Years with Acute M...Onyee Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts Outcome61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- RUNX1 Mutation Is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia Receiving Allogeneic Stem Cell Transplantation61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: